Park Medi World shares jumped 10% following Emkay Research's 'Buy' rating and a target price of ₹350, suggesting a 35% potential rise. Strong business model, asset efficiency, and expansion plans highlight the company's competitive edge in healthcare.
Park Medi World shares jumped 10% following Emkay Research's 'Buy' rating and a target price of ₹350, suggesting a 35% potential rise. Strong business model, asset efficiency, and expansion plans highlight the company's competitive edge in healthcare.
<iframe src="https://hindustansphere.com/embed/cluster/cc51baae45a96a1cc77def2c80a28adea15bf7f0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Health stock Park Medi World jumps 10% despite stock market crash. Emkay sees over 25% more upside"></iframe>
